Evidence mapPaperPMID 39657663Full record

ArticleCell reports. Medicine2024

A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury.

Kylie A Alexander, Hsu-Wen Tseng, Hong Wa Lao, Dorothée Girard, Valérie Barbier, Jacobus P J Ungerer, Brett C McWhinney, Selwin G Samuel, Whitney Fleming, Ingrid G Winkler and 5 more

Abstract read
In one paragraph

Article in Cell reports. Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kylie A AlexanderMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia. Electronic address: kylie.alexander@mater.uq.edu.au.
Hsu-Wen TsengMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Hong Wa LaoSchool of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4067, Australia.
Dorothée GirardInstitut de Recherche Biomédicale des Armées, 92140 Clamart, France; INSERM, UMR-MD U1197 SToRM, 92140 Clamart, France.
Valérie BarbierMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Jacobus P J UngererSchool of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4067, Australia; Department of Chemical Pathology, Pathology Queensland, Herston, QLD 4029, Australia.
Brett C McWhinneyDepartment of Chemical Pathology, Pathology Queensland, Herston, QLD 4029, Australia.
Selwin G SamuelMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Whitney FlemingMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Ingrid G WinklerMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Marjorie SalgaUnité Péri-Opératoire du Handicap, Physical and Rehabilitation Medicine Department, Hôpital Raymond-Poincaré, Assistance Publique Hôpitaux de Paris (APHP), 92380 Garches, France.
François GenêtUnité Péri-Opératoire du Handicap, Physical and Rehabilitation Medicine Department, Hôpital Raymond-Poincaré, Assistance Publique Hôpitaux de Paris (APHP), 92380 Garches, France; Université Versailles Saint-Quentin-en-Yvelines, UFR Simone Veil - Santé, END:ICAP, INSERM U1179, 78180 Montigny-le-Bretonneux, France.
Sébastien BanzetInstitut de Recherche Biomédicale des Armées, 92140 Clamart, France; INSERM, UMR-MD U1197 SToRM, 92140 Clamart, France.
Marc J RuitenbergSchool of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD 4067, Australia.
Jean-Pierre LévesqueMater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia. Electronic address: jp.levesque@mater.uq.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Why severe injury to the central nervous system (CNS) triggers the development of large neurogenic heterotopic ossifications (NHOs) within periarticular muscles remains unknown. We report that spinal cord injury (SCI) triggers a rapid corticosterone spike in mice, which is causal for NHO development because treatments with corticosterone or the synthetic glucocorticoid (GC) receptor (GR) agonist dexamethasone are sufficient to trigger heterotopic ossification and upregulate the expression of osteoinductive and osteogenic differentiation genes in injured muscles even without SCI. The central role for GR signaling in causing NHO is further demonstrated in mice deleted for the GR gene (Nr3c1), which no longer develop NHO after SCI. Furthermore, administration of clinical GR antagonists inhibits NHO development in mice with SCI. This study identifies endogenous GC as causing pathological NHO after CNS injury and suggests that GR antagonists may be of prophylactic use to prevent NHO development in victims of severe CNS injuries.

Indexed as

GlucocorticoidsOssification, HeterotopicReceptors, GlucocorticoidSpinal Cord InjuriesAnimalsCorticosteroneDexamethasoneMaleMiceMice, Inbred C57BLCorticosteroneDexamethasoneGlucocorticoidsReceptors, Glucocorticoiddexamethasonefibroadipogenic progenitorGlucocorticoid receptorinflammationmifepristonemuscle repairneurogenic heterotopic ossificationosteoblastrelacorilantspinal cord injury

Identifiers

PMID39657663
PMCPMC11722129

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.